FIELD: medicine.
SUBSTANCE: content of erythropoietin is determined in blood plasma by method of enzymatically amplified chemiluminiscence analysis. If content of erythropoietin is higher than 17.6 IU/l, initial stage of chronic renal failure is diagnosed.
EFFECT: application of claimed method makes it possible to increase test accuracy, reduce time of the test and make it cheaper.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
EARLY DIAGNOSTIC TECHNIQUE FOR CHRONIC RENAL DISEASE | 2013 |
|
RU2566709C2 |
DIAGNOSTIC TECHNIQUE FOR STAGES OF CHRONIC KIDNEY DISEASE | 2013 |
|
RU2565394C2 |
METHOD FOR DIAGNOSTICS OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2641964C1 |
METHOD OF PREDICTING THE DEVELOPMENT OF RISK AND PROGRESSION OF CHRONIC KIDNEY DISEASE IN CHILDREN WITH A TYPICAL FORM OF HEMOLYTIC UREMIC SYNDROME | 2022 |
|
RU2797633C1 |
DIAGNOSTIC TECHNIQUE OF CHRONIC RENAL INSUFFICIENCY | 2008 |
|
RU2414705C2 |
METHOD FOR DIAGNOSING FUNCTIONAL RENAL RESERVE | 1998 |
|
RU2143700C1 |
METHOD FOR DIAGNOSING EARLY CHRONIC RENAL DISEASE IN CHILDREN | 2020 |
|
RU2753581C1 |
METHOD FOR ASSESSING GLOMERULE SCLEROSIS IN ACUTE NEPHRITIC SYNDROME | 2010 |
|
RU2428697C1 |
METHOD OF EARLY DIAGNOSTICS OF KIDNEY DAMAGE IN PATIENTS WITH THE INITIAL STAGE OF CHRONIC KIDNEY DISEASE | 2018 |
|
RU2677289C1 |
METHOD OF ASSESSING EFFECTIVENESS OF NEPHROPROTECTIVE THERAPY IN HYPERTENSIVE PATIENTS WITH STAGE C2 CHRONIC KIDNEY DISEASE | 2023 |
|
RU2810453C1 |
Authors
Dates
2013-09-10—Published
2011-10-27—Filed